Design, synthesis and α-glucosidase inhibition study of novel embelin derivatives
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 35 (1) , 565-573
Abstract
Embelin is a naturally occurring para-benzoquinone isolated from Embelia ribes (Burm. f.) of the Myrsinaceae family. It was first discovered to have potent inhibitory activity (IC50 = 4.2 μM) against α-glucosidase in this study. Then, four series of novel embelin derivatives were designed, prepared and evaluated in α-glucosidase inhibition assays. The results show that most of the embelin derivatives synthesised are effective α-glucosidase inhibitors, with IC50 values at the micromolar level, especially 10d, 12d, and 15d, the IC50 values of which are 1.8, 3.3, and 3.6 μM, respectively. Structure–activity relationship (SAR) studies suggest that hydroxyl groups in the 2/5-position of para-benzoquinone are very important, and long-chain substituents in the 3-position are highly preferred. Moreover, the inhibition mechanism and kinetics studies reveal that all of 10d, 12d, 15d, and embelin are reversible and mixed-type inhibitors. Furthermore, docking experiments were carried out to study the interactions between 10d and 15d with α-glucosidase.Keywords
Funding Information
- Error! Hyperlink reference not valid. (2016A030310441)
- National Natural Science Foundation of China (81803390)
- Special Fund Project of Science and Technology Innovation Strategy in Guangdong Province
- Jiangmen Science and Technology Project of Basic and Theoretical Science Research (2019030102100008866)
- Science Foundation for Young Teachers of Wuyi University (2016td01)
- the Foundation of Department of Education of Guangdong Province (2017KQNCX200, 2017KSYS010)
- Innovation and Entrepreneurship Training Program for Undergraduates of Guangdong Province
This publication has 31 references indexed in Scilit:
- Anti-diabetic activity of embelin: Involvement of cellular inflammatory mediators, oxidative stress and other biomarkersPhytomedicine, 2013
- Evaluation of anxiolytic activity of embelin isolated from Embelia ribesBiomedicine & Aging Pathology, 2012
- The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectivesNature Reviews Endocrinology, 2011
- Evaluation of antidiabetic effect of embelin from Embelia ribes in alloxan induced diabetes in ratsBiomedicine & Preventive Nutrition, 2011
- Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetesMetabolism, 2011
- α-glucosidase inhibitors from plants: A natural approach to treat diabetesPharmacognosy Reviews, 2011
- Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weightInternational Journal Of Clinical Practice, 2007
- Free radical scavenging reactions and antioxidant activity of embelin: Biochemical and pulse radiolytic studiesChemico-Biological Interactions, 2007
- α-Glucosidase Inhibitors for Patients With Type 2 DiabetesDiabetes Care, 2005
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2004